Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin Guscott
Institution:
Resonance (United States)
Observed institution:
Resonance (United States)
ORCID:
0000-0001-7842-1559
Observed ORCID:
0000-0001-7842-1559
OpenAlex ID:
A5028106700
A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma
2023
·
Gabriela Villanueva
, Martin Guscott
, et al.
·
Cancers
·
27
PDF
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing
2022
·
Manuel Ibarra
, Ryan Combs
, et al.
·
British Journal of Clinical Pharmacology
·
12
RETRACTED ARTICLE: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid
2025
·
Jesper Heldrup
, Archie Bleyer
, et al.
·
Cancer Chemotherapy and Pharmacology
·
6
Strategies for Managing Toxicities With High‐Dose Methotrexate in Haematological Malignancies: Lessons From Clinical Cases
2026
·
Vanessa McLelland
, Martin Guscott
, et al.
·
Clinical Case Reports
·
2
The Price of Survival: Global Inequities in Anti‐GD2 Immunotherapy for Neuroblastoma
2026
·
Ruzanna Papyan
, Julieta Hoveyan
, et al.
·
Pediatric Blood & Cancer
·
1
Retraction Note: New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid
2025
·
Jesper Heldrup
, Archie Bleyer
, et al.
·
Cancer Chemotherapy and Pharmacology
PDF
Show more works
View as search
Works count:
6
Citation count:
48
H-index:
3
I10-index:
2
Year
Topic
Type
